Azenta, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2023
November 13, 2023 at 04:07 pm EST
Share
Azenta, Inc. reported earnings results for the fourth quarter and full year ended September 30, 2023. For the fourth quarter, the company reported revenue was USD 172.36 million compared to USD 137.57 million a year ago. Net income was USD 3.38 million compared to net loss of USD 20.76 million a year ago. Basic earnings per share from continuing operations was USD 0.05 compared to basic loss per share from continuing operations of USD 0.07 a year ago. Diluted earnings per share from continuing operations was USD 0.05 compared to diluted loss per share from continuing operations of USD 0.07 a year ago. Basic earnings per share was USD 0.06 compared to basic loss per share of USD 0.28 a year ago. Diluted earnings per share was USD 0.06 compared to diluted loss per share of USD 0.28 a year ago.
For the full year, revenue was USD 665.07 million compared to USD 555.5 million a year ago. Net loss was USD 14.26 million compared to net income of USD 2,132.86 million a year ago. Basic loss per share from continuing operations was USD 0.19 compared to USD 0.15 a year ago. Diluted loss per share from continuing operations was USD 0.19 compared to USD 0.15 a year ago. Basic loss per share was USD 0.22 compared to basic earnings per share of USD 28.48 a year ago. Diluted loss per share was USD 0.22 compared to diluted earnings per share of USD 28.48 a year ago.
Azenta, Inc. is a provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Companyâs segments include Sample Management Solutions, Multiomics and B Medical Systems. The Sample Management Solutions segment offers end-to-end sample management products and services, including sample and repository services and core products (automated stores, cryogenic systems, automated sample tube, and consumables and instruments). The Multiomics segment provides genomic and other sample analysis services, including gene sequencing and gene synthesis. B Medical Systems segment is focused on the manufacturing and distribution of temperature-controlled storage and transportation solutions in international markets to governments, health institutions, and non-government organizations. It provides products and services through its brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, Barkey, and B Medical Systems.
AZENTA, INC. 
